Abstract 5487: Improved spatial biology analysis of the tumor microenvironment with the next generation of the MultiOmyxTMplatform

Michael Lazare,Harry Nunns,Fatemeh Jelvhei Moghaddam,Xiaowei Jin,Courtney Todorov,Eric Leones,Marianne Thio,Flora Sahafi,Erinn Parnell,Qingyan Au

DOI: https://doi.org/10.1158/1538-7445.am2024-5487

IF: 11.2

2024-03-22

Cancer Research

Abstract:Abstract Multiplexed Immunofluorescence is a powerful tool for spatially characterizing and phenotyping cells within the tumor microenvironment. MultiOmyx has been one of the leading platforms for generating multiplexed immunofluorescence data to support translational and clinical research for more than 10 years. However, MultiOmyx and other similar platforms are often hampered by a limited imaging area due to either restricted staining areas or being cost prohibitive due to excessive imaging times. Here, we demonstrate the capabilities of an improved MultiOmyx platform which can be used to generate whole-tissue data from the iterative MultiOmyx multiplexing process using the CyteFinder® II microscope and a customized software package developed by RareCyte, Inc. The new NeoLYTX image analysis pipeline in conjunction with the whole-tissue image output allows for improved interaction with pathologists, better histological context, and unbiased spatial analysis. In this study we utilized a 16-marker panel consisting of CD3, CD4, CD8, FoxP3, CD20, CD68, CD163, HLA-DR, PD-1, PD-L1, CTLA-4, CD34, Vimentin, SOX10, Ki67, and PanCK to generate immune profiles for colorectal carcinoma, prostate carcinoma, non-Small cell lung cancer, and triple negative breast cancer samples. We showed concordance with the current MultiOmyx imager - the IN Cell 2200 - for each of the markers in the panel. Additionally, we demonstrated that the updates made to the proprietary NeoLYTX image analysis pipeline are able to facilitate the significantly larger data sets that will be generated with the new MultiOmyx platform. This study successfully demonstrates the capability of the improved MultiOmyx system to characterize the distribution of T-cell and myeloid phenotypes in the tumor microenvironment using the proven MultiOmyx workflow, now enhanced by whole slide images and analysis. Citation Format: Michael Lazare, Harry Nunns, Fatemeh Jelvhei Moghaddam, Xiaowei Jin, Courtney Todorov, Eric Leones, Marianne Thio, Flora Sahafi, Erinn Parnell, Qingyan Au. Improved spatial biology analysis of the tumor microenvironment with the next generation of the MultiOmyxTMplatform [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 5487.

oncology